Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study

The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly

(2011) C. N. Jayasena et al.   CLINICAL ENDOCRINOLOGY

Cardiovascular Risk Factors in Patients with Uncontrolled and Long-Term Acromegaly: Comparison with Matched Data from the General Population and the Effect of Disease Control

(2010) Christian Berg et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities

(2009) Eugenia Resmini et al.   ACTA DIABETOLOGICA

The GH-IGF-I axis and the cardiovascular system: clinical implications

(2008) Annamaria Colao   CLINICAL ENDOCRINOLOGY

GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment

(2008) Annamaria Colao et al.   CLINICAL ENDOCRINOLOGY

European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies

(2008) A. Evangelista et al.   European Journal of Echocardiography

A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly

(2008) I M Holdaway et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects

(2008) Annamaria Colao et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Mortality in Acromegaly: A Metaanalysis

(2007) O. M. Dekkers et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM